Identification of AKT1/β-catenin mutations  conferring cetuximab and chemotherapeutic drug  resistance in colorectal cancer treatment

dc.contributor.author	Aksoy Sağırlı, Pınar
dc.contributor.author	Altıparmak Ülbegi, Gülsüm
dc.contributor.author	Can, Ayşe
dc.contributor.author	Hasbal Çelikok, Gözde
dc.date.accessioned	2021-02-28T14:23:03Z
dc.date.available	2021-02-28T14:23:03Z
dc.date.issued	2021
dc.identifier.citation	Hasbal Çelikok G., Aksoy Sağırlı P., Altıparmak Ülbegi G., Can A., "Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment", Oncology Letters, cilt.21, ss.1-10, 2021
dc.identifier.issn	1792-1074
dc.identifier.other	vv_1032021
dc.identifier.other	av_e9c4de3f-a392-4ec2-8c35-71d1a1de3a88
dc.identifier.uri	http://hdl.handle.net/20.500.12627/1404
dc.identifier.uri	https://doi.org/10.3892/ol.2021.12470
dc.identifier.uri	https://avesis.istanbul.edu.tr/api/publication/e9c4de3f-a392-4ec2-8c35-71d1a1de3a88/file
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	Sağlık Bilimleri
dc.title	Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment
dc.type	Makale
dc.relation.journal	Oncology Letters
dc.contributor.department	İstanbul Üniversitesi, Eczacılık Fakültesi, Biyokimya Anabilim Dalı
dc.identifier.volume	21
dc.identifier.issue	209
dc.identifier.startpage	1
dc.identifier.endpage	10
dc.contributor.firstauthorID	2507347